24 Nov

Opyl - Change of Directors Interest Notice - Dr J Chick

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/20 11 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/ 0 9/01 Amended 01/01/11 Name of entity Opyl Limited ABN 71 063 144 865 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director J ulian Ch ick Date of last notice 2 4 April 202 1 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a co mpa n y, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indire ct Nature of indirect interest (including registered holder) Note: Provide details o f the circumstances giving rise to the relevant interest. 1.  2. DR V TRAICEV SKI Date of change 23 Nove mber 202 1 Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appe ndix 3Y Page 2 01/01/20 11 No. of securities held prior to change 1. 30,000 U nlis ted options (exercise price $0.60 and expiry dat e 20 F ebruary 2023) 2. 20 , 000 Unlisted options (exercise price $0. 30 and expiry date 10 December 202 4) 3. 109,998 Unlisted opt i o ns (exer ci se price $0.50 and expiry date 13 May 2024 ) 4. 2 5,000 Unlisted options (exercise price $0.50 and expiry date 4 May 2023) 5. 300,00 0 Unlisted o pti on s (100 ,000 wi th e xercise price $0.30 , 100,000 with exer cise price $ 0.50, and 100,000 with ex ercise price $0.75 , and expiry date 10 December 2025) 6. 464,741 Fully paid ordinary shares Class Fully paid ordinary shares Number acquired 73,500 Fully p aid ordinary sh ares Number disposed Nil Value/Consideration Note: If consideration is non - cash, provide details and estimated valuation 73,500 shares at 14.28 cents per share No. of securities held aft er change 1. 30,000 U nlis ted options (exercise p rice $0.60 and exp iry d ate 20 F ebruary 2023) 2. 20 , 000 Unlisted options (exercise price $0. 30 and expiry date 10 December 202 4) 3. 109,998 Unlisted opt i o ns (exer ci se price $0.50 and expiry date 13 May 2024 ) 4. 2 5,000 Unlisted options (exercise price $0.50 and expir y date 4 May 2023) 5. 300, 000 Unlisted o pti on s (100,000 wi th e xercise price $0.30 , 100,000 with exer cise price $ 0.50, and 100,000 with ex ercise price $0.75 , and expiry date 10 December 2025) 6. 688,241 Fully paid ordinary shares Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/20 11 Appendix 3Y Page 3 Nature of change Example: on - mar ket trade, off - mar ket t rade, exercise of options, issue of securities under dividend reinvestment plan, p articipation in buy - back On - market share purchase Part 2 – Change of director’s interests in contracts Note: In the case o f a company, interests which come within par agraph (ii) of the definition of “notifiable interest of a di rector” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Dat e of change N/A No. an d class of securities t o which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note : If consideration is n on - cash, provide deta ils and an estimated valuation N/A Interest after change N /A Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clear ance was required? No If so, was prior writ ten clearance provi ded to allow the trade to proceed during t his period? N/A If prior written clearance was provided, on what date was this provided? N/A
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Opyl Limited (ASX:OPL) when you join Listcorp.